Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001384243-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-12 | 2026-02-10+ | KNSA | Quart Barry D | Dir | S - Sale+OE | $45.00 | -2,800 | 12.5K | -18% | -$126.0K |
| DM | 2026-02-12 | 2026-02-10+ | KNSA | Quart Barry D | Dir | M - OptEx | $15.47 | +2,800 | 12.7K | +28% | +$43.3K |
| DM | 2026-02-12 | 2026-02-10+ | KNSA | Quart Barry D | Dir | M - OptEx | $0.00 | -2,800 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-02-12 | S | D | 2,690 | $45.00 | 12,546 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2026-02-12 | M | A | 2,690 | $15.47 | 15,236 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2026-02-10 | S | D | 110 | $45.00 | 12,546 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2026-02-10 | M | A | 110 | $15.47 | 12,656 | D | — | — | |
| 5 | Derivative | Share Option | 2026-02-10 | M | D | 110 | $0.00 | 2,690 | D | $15.47 · — to 2029-05-28 | 110 Class A Ordinary Shares | (F2) The option is fully vested and exercisable. |
| 6 | Derivative | Share Option | 2026-02-12 | M | D | 2,690 | $0.00 | 0 | D | $15.47 · — to 2029-05-28 | 2,690 Class A Ordinary Shares | (F2) The option is fully vested and exercisable. |